Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 1;45(12):825-827.
doi: 10.1097/DAD.0000000000002570.

Preordering Periodic Acid-Schiff Staining: A Quality Improvement Study

Zachary J Wolner  1   2 , Danielle E Mustin  1 , Benjamin K Stoff  1   2
Affiliations
Review

Preordering Periodic Acid-Schiff Staining: A Quality Improvement Study

Zachary J Wolner et al. Am J Dermatopathol. .

Abstract

Periodic acid-Schiff (PAS) stain is a commonly used ancillary test for inflammatory and infectious dermatoses, yet infrequently changes the diagnosis. Previous studies have shown that clinical suspicion and histopathologic features are poor predictors of PAS positivity. Current appropriate use criteria from the American Society of Dermatopathology supports PAS staining when histopathologic features could be consistent with a dermatophyte infection. At the authors' institution, PAS stains are preordered on biopsies of inflammatory and infectious diagnoses to aid in a timelier sign out. Our aim was to reduce the percentage of PAS stains preordered on all dermatology specimens over a 6-month period without reducing the percentage of fungal infections identified. Review of a 12-month preintervention period found that our laboratory received 6104 biopsies for which PAS stain was preordered on 616 (10.1%). Based on a review of the preintervention period, preordering PAS on cases with clinical suspicion for cutaneous T-cell lymphoma was stopped unless there was clinical suspicion for eczematous dermatitis, vesiculobullous disorders, or fungal infection. The proposed intervention resulted in a 3.7% reduction in the number of PAS stains ordered while PAS-positivity rate remained unchanged. The described quality improvement process may be used as a model for other laboratories.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Shalin SC, Ferringer T, Cassarino DS. PAS and GMS utility in dermatopathology: review of the current medical literature. J Cutan Pathol. 2020;47:1096–1102.
    1. Al-Amiri A, Chatrath V, Bhawan J, et al. The periodic acid-Schiff stain in diagnosing tinea: should it be used routinely in inflammatory skin diseases? J Cutan Pathol. 2003;30:611–615.
    1. Wang MZ, Guo R, Lehman JS. Correlation between histopathologic features and likelihood of identifying superficial dermatophytosis with periodic acid Schiff-diastase staining: a cohort study. J Cutan Pathol. 2017;44:152–157.
    1. Fung MA, Vidal CI, Armbrecht EA, et al. Appropriate use criteria for ancillary diagnostic testing in dermatopathology: new recommendations for 11 tests and 220 clinical scenarios from the American Society of Dermatopathology Appropriate Use Criteria Committee. J Cutan Pathol. 2022;49:231–245.
    1. Centers for Medicare & Medicaid Services. Lab: Special Histochemical Stains and Immunohistochemical Stains, 2017. Available at: https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=36805 . Accessed August 27, 2023.